Information Age Audits

Noferi,Joseph;Worden,Daniel;Arling,Edward;

Publication

Article

January 15, 2002

BioPharm International

BioPharm International-01-01-2002

Volume15

Issue 1

Information Age Audits

Author(s):

Joseph F. Noferi, Esq.,Daniel E. Worden

by Joseph F. Noferi, Daniel E. Worden, and Edward R. Arling Understanding the reach of 21 CFR Part 11 is the first step to assessing its impact. To protect your company, you need integrated quality audit solutions to evaluate the underlying validation of your electronic data.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaboration

Inside Washington: Biotechnology in the Limelight, the Year Ahead

Your Vested Interests: The War of the West

Statistics for Laboratory Method Comparison Studies

From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continues

Systematic Troubleshooting for LC/MS/MS: Part 2, Large-Scale LC/MS/MS and Automation

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!